Livzon Pharmaceutical Group (1513) Cash flow

1 Followers

Livzon Pharmaceutical Group Cash Flow

HK:1513's free cash flow for Q4 2025 was ¥546.70M. For the 2025 fiscal year, HK:1513's free cash flow was decreased by ¥128.74M and operating cash flow was ¥626.14M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	¥ 3.10B	¥ 2.98B	¥ 3.25B	¥ 2.77B	¥ 1.90B
Investing Cash Flow	¥ -3.67B	¥ -660.33M	¥ -708.37M	¥ -1.23B	¥ -1.88B
Financing Cash Flow	¥ -2.62B	¥ -2.49B	¥ -1.66B	¥ -720.36M	¥ -815.02M
End Cash Position	¥ 9.31B	¥ 10.82B	¥ 10.98B	¥ 10.07B	¥ 9.13B
Free Cash Flow	¥ 2.54B	¥ 2.41B	¥ 2.43B	¥ 1.83B	¥ 593.23M

Currency in CNY